A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/1998
11/24/1998	US5840299 Binding and treatment of multiple sclerosis
11/24/1998	CA2108584C Substituted azetidinones as anti-inflammatory and antidegenerative agents
11/23/1998	CA2232810A1 Novel compounds
11/23/1998	CA2232809A1 Novel compounds
11/23/1998	CA2232808A1 Novel compounds
11/23/1998	CA2230996A1 Novel compounds
11/23/1998	CA2221837A1 A novel human gene similar to a secreted protein frizb (atg-1639)
11/23/1998	CA2221836A1 A novel human gene similar to a secreted murine protein sfrp-1
11/22/1998	CA2231017A1 A member of the frzb family, frazzled
11/22/1998	CA2221688A1 Atg-1120 (aif-1-delta), a novel splice variant of aif-1/rc-9
11/20/1998	WO1998052549A2 Use of fumaric acid derivatives
11/19/1998	WO1998051684A1 Antithrombotic compound
11/19/1998	WO1998051662A2 Compounds and methods for the inhibition of the expression of vcam-1
11/19/1998	WO1998051348A2 Sustained-release delayed gels
11/19/1998	WO1998051325A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
11/19/1998	WO1998051321A1 Tissue factor for influencing blood vessel formation
11/19/1998	WO1998051299A1 Patches containing isosorbide nitrate
11/19/1998	WO1998051291A1 Use of a pharmaceutical composition for treating and/or preventing ischemia
11/19/1998	WO1998051289A2 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
11/19/1998	CA2428130A1 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
11/19/1998	CA2290756A1 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
11/19/1998	CA2289625A1 Antithrombotic compound
11/19/1998	CA2288117A1 Tissue factor for influencing blood vessel formation
11/19/1998	CA2287363A1 Use of a pharmaceutical composition for treating and/or preventing ischemia
11/19/1998	CA2221866A1 A novel member of the il-1 family, il-1 delta
11/18/1998	EP0878542A2 cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor
11/18/1998	EP0878479A2 G-protein coupled receptor (HOFNH30)
11/18/1998	EP0878467A1 Substituted 6- and 7-aminotetrahydroisoquinolinecarboxylic acids
11/18/1998	EP0878195A1 Use of a 2-aroyl-3-arylbenzo(b)thiophene compound for reducing fibrinogen
11/18/1998	EP0877943A1 Methods for measurement and treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts
11/18/1998	EP0877806A1 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
11/18/1998	EP0877804A1 Inhibitors of cell-cycle progression, and uses related thereto
11/18/1998	EP0877759A1 Methods for increasing endogenous levels of corticotropin-releasing factor
11/18/1998	EP0877750A1 Sugar-substituted 2-azetidinones useful as hypocholesterolemic a gents
11/18/1998	EP0877748A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
11/18/1998	EP0877747A1 Azaspiro derivatives with 5ht 1b? activity
11/18/1998	EP0877743A1 ((3"-thioxacyclohex-1"-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity
11/18/1998	EP0877740A1 Thiol derivatives with metallopeptidase inhibitory activity
11/18/1998	EP0877734A1 Quinoline and quinazoline compounds useful in therapy
11/18/1998	EP0877626A2 Anti-cd18 antibodies for use against stroke
11/18/1998	EP0877616A1 Medicaments containing aromatic azo compounds
11/18/1998	EP0877605A2 Solid instant-release forms of administration and process for producing the same
11/18/1998	EP0757669B1 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them
11/18/1998	EP0537201B1 1-[4-(imidazol-1-yl)benzoyl]piperidine derivatives as antiarrhythmic agents
11/18/1998	CN1199398A 1-[2-(2,3-dihydro-1H-inden-1-yl) ethyl]-4-(naphthalen-1-yl) piperazine derivs, preparation thereof and therapeutical use thereof
11/18/1998	CN1199337A Method of inhibiting plasminogen activator inhibitor 1
11/18/1998	CN1199045A Substituted 6- and 7-aminotetrahydroisoquinolinecarboxylic acids
11/18/1998	CN1198945A Gingko-Ribes burejense capsule
11/18/1998	CN1040758C Process for preparation of crystalline fumarate of diazabiscyclic nonane
11/18/1998	CN1040753C Pyridine derivs. and preparation process thereof
11/17/1998	US5837823 Antibodies to adrenomedullin
11/17/1998	US5837727 Method for altering blood lipid levels
11/17/1998	US5837712 Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations
11/17/1998	US5837707 Dimeric piperidine, tetrahydropyridine and piperazine derivatives
11/17/1998	US5837702 4-arylamino-benzopyran and related compounds
11/17/1998	US5837680 Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis
11/17/1998	US5837499 Genetic engineering with polypeptides and dna molecules
11/17/1998	US5837451 Identifying composition which affect kinase activity
11/17/1998	US5837244 Treating a cell proliferative disorder
11/13/1998	CA2237382A1 Substituted 6- and 7-amino-tetrahydroisoquinolinecarboxylic acids
11/13/1998	CA2230971A1 G-protein coupled receptor (hofnh30)
11/12/1998	WO1998050420A1 Serine protease inhibitors
11/12/1998	WO1998050414A1 B-ring estratriene diol sulphates
11/12/1998	WO1998050412A1 Estrogenic 19-noradnrost-17-one derivatives with an aromatic b-ring
11/12/1998	WO1998050394A1 Nitric oxide carriers based on polyazamacrocycle complexes
11/12/1998	WO1998050383A1 5-phenyl-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands
11/12/1998	WO1998050382A1 Amidine derivatives as inhibitors of nitric oxide synthase
11/12/1998	WO1998050380A1 Compounds
11/12/1998	WO1998050372A1 Substituted heterocycles and their use in medicaments
11/12/1998	WO1998050356A1 2-indolinone derivatives as modulators of protein kinase activity
11/12/1998	WO1998050079A2 Techniques and compositions for treating heart failure and ventricular remodeling by in vivo delivery of angiogenic transgenes
11/12/1998	WO1998050073A1 Integrin ligand, human mindin
11/12/1998	WO1998050057A2 Agent for enhancing the heart force
11/12/1998	WO1998050048A1 Aplidine as an l-type calcium channel enhancer
11/12/1998	WO1998050032A1 BETA-LACTAM INHIBITORS OF CoA-IT
11/12/1998	WO1998050031A1 Inhibitors of protein isoprenyl transferases
11/12/1998	WO1998050030A1 Inhibitors of protein isoprenyl transferases
11/12/1998	WO1998050029A1 Inhibitors of protein isoprenyl transferases
11/12/1998	WO1998050028A1 Mtp inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels
11/12/1998	WO1998049970A1 N-methyl-d-aspartate (nmda) receptor blockers for the prevention of atherosclerosis
11/12/1998	WO1998049897A1 Beta lactams as antiproliferative agents
11/12/1998	CA2289705A1 Beta lactams as antiproliferative agents
11/12/1998	CA2289102A1 2-indolinone derivatives as modulators of protein kinase activity
11/12/1998	CA2289011A1 B-ring estratriene diol sulphates
11/12/1998	CA2289001A1 Novel heterocyclic compounds
11/12/1998	CA2288999A1 B-ring estratrienes
11/12/1998	CA2288986A1 Beta-lactam inhibitors of coa-it
11/12/1998	CA2288639A1 Aplidine as an l-type calcium channel enhancer
11/12/1998	CA2288333A1 Amidine derivatives as inhibitors of nitric oxide synthase
11/12/1998	CA2288330A1 Benzoyl amino acid derivatives useful as inhibitors of protein isoprenyl tranferases
11/12/1998	CA2288149A1 N-methyl-d-aspartate (nmda) receptor blockers for the prevention of atherosclerosis
11/12/1998	CA2287999A1 Compounds
11/12/1998	CA2287981A1 Nitric oxide carriers based on polyazamacrocycle complexes
11/12/1998	CA2287569A1 Serine protease inhibitors
11/12/1998	CA2286341A1 Mtp inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels
11/11/1998	EP0877083A1 A novel human G-protein coupled receptor (HCEPT09)
11/11/1998	EP0877025A1 Substituted 6-h-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
11/11/1998	EP0877019A1 Substituted diaminocarboxylic acid
11/11/1998	EP0877018A1 Sulfonylaminocarboxylic acids
11/11/1998	EP0876395A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME

1 ... 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 ... 1595